nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—CYP1A2—Dacarbazine—pancreatic cancer	0.122	0.327	CbGbCtD
Frovatriptan—CYP1A2—Tamoxifen—pancreatic cancer	0.0974	0.26	CbGbCtD
Frovatriptan—CYP1A2—Erlotinib—pancreatic cancer	0.0828	0.221	CbGbCtD
Frovatriptan—CYP1A2—Fluorouracil—pancreatic cancer	0.0718	0.192	CbGbCtD
Frovatriptan—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000583	0.00114	CcSEcCtD
Frovatriptan—Dehydration—Epirubicin—pancreatic cancer	0.00058	0.00114	CcSEcCtD
Frovatriptan—Insomnia—Gemcitabine—pancreatic cancer	0.000579	0.00114	CcSEcCtD
Frovatriptan—Dyspepsia—Irinotecan—pancreatic cancer	0.000578	0.00114	CcSEcCtD
Frovatriptan—Headache—Erlotinib—pancreatic cancer	0.000577	0.00113	CcSEcCtD
Frovatriptan—Pain in extremity—Doxorubicin—pancreatic cancer	0.000577	0.00113	CcSEcCtD
Frovatriptan—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000577	0.00113	CcSEcCtD
Frovatriptan—Paraesthesia—Gemcitabine—pancreatic cancer	0.000575	0.00113	CcSEcCtD
Frovatriptan—Chills—Docetaxel—pancreatic cancer	0.000574	0.00113	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000573	0.00113	CcSEcCtD
Frovatriptan—Asthenia—Sunitinib—pancreatic cancer	0.000572	0.00112	CcSEcCtD
Frovatriptan—Decreased appetite—Irinotecan—pancreatic cancer	0.000571	0.00112	CcSEcCtD
Frovatriptan—Arrhythmia—Docetaxel—pancreatic cancer	0.000571	0.00112	CcSEcCtD
Frovatriptan—Dyspnoea—Gemcitabine—pancreatic cancer	0.000571	0.00112	CcSEcCtD
Frovatriptan—Insomnia—Fluorouracil—pancreatic cancer	0.000569	0.00112	CcSEcCtD
Frovatriptan—Somnolence—Gemcitabine—pancreatic cancer	0.000569	0.00112	CcSEcCtD
Frovatriptan—Migraine—Doxorubicin—pancreatic cancer	0.000568	0.00111	CcSEcCtD
Frovatriptan—Affect lability—Doxorubicin—pancreatic cancer	0.000568	0.00111	CcSEcCtD
Frovatriptan—Fatigue—Irinotecan—pancreatic cancer	0.000566	0.00111	CcSEcCtD
Frovatriptan—Paraesthesia—Fluorouracil—pancreatic cancer	0.000565	0.00111	CcSEcCtD
Frovatriptan—Pruritus—Sunitinib—pancreatic cancer	0.000564	0.00111	CcSEcCtD
Frovatriptan—Pain—Irinotecan—pancreatic cancer	0.000562	0.0011	CcSEcCtD
Frovatriptan—Constipation—Irinotecan—pancreatic cancer	0.000562	0.0011	CcSEcCtD
Frovatriptan—Dyspnoea—Fluorouracil—pancreatic cancer	0.000561	0.0011	CcSEcCtD
Frovatriptan—Mental disorder—Docetaxel—pancreatic cancer	0.00056	0.0011	CcSEcCtD
Frovatriptan—Somnolence—Fluorouracil—pancreatic cancer	0.000559	0.0011	CcSEcCtD
Frovatriptan—Malnutrition—Docetaxel—pancreatic cancer	0.000556	0.00109	CcSEcCtD
Frovatriptan—Decreased appetite—Gemcitabine—pancreatic cancer	0.000556	0.00109	CcSEcCtD
Frovatriptan—Dyspepsia—Fluorouracil—pancreatic cancer	0.000554	0.00109	CcSEcCtD
Frovatriptan—Nausea—Tamoxifen—pancreatic cancer	0.000553	0.00109	CcSEcCtD
Frovatriptan—Fatigue—Gemcitabine—pancreatic cancer	0.000552	0.00108	CcSEcCtD
Frovatriptan—Muscular weakness—Epirubicin—pancreatic cancer	0.00055	0.00108	CcSEcCtD
Frovatriptan—Constipation—Gemcitabine—pancreatic cancer	0.000547	0.00107	CcSEcCtD
Frovatriptan—Pain—Gemcitabine—pancreatic cancer	0.000547	0.00107	CcSEcCtD
Frovatriptan—Nausea—Erlotinib—pancreatic cancer	0.000547	0.00107	CcSEcCtD
Frovatriptan—Decreased appetite—Fluorouracil—pancreatic cancer	0.000547	0.00107	CcSEcCtD
Frovatriptan—Mood swings—Doxorubicin—pancreatic cancer	0.000546	0.00107	CcSEcCtD
Frovatriptan—Diarrhoea—Sunitinib—pancreatic cancer	0.000546	0.00107	CcSEcCtD
Frovatriptan—Dysgeusia—Docetaxel—pancreatic cancer	0.000545	0.00107	CcSEcCtD
Frovatriptan—Ataxia—Doxorubicin—pancreatic cancer	0.000542	0.00106	CcSEcCtD
Frovatriptan—Feeling abnormal—Irinotecan—pancreatic cancer	0.000541	0.00106	CcSEcCtD
Frovatriptan—Dysphagia—Epirubicin—pancreatic cancer	0.000539	0.00106	CcSEcCtD
Frovatriptan—Back pain—Docetaxel—pancreatic cancer	0.000538	0.00106	CcSEcCtD
Frovatriptan—Pain—Fluorouracil—pancreatic cancer	0.000538	0.00106	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000537	0.00105	CcSEcCtD
Frovatriptan—Dehydration—Doxorubicin—pancreatic cancer	0.000536	0.00105	CcSEcCtD
Frovatriptan—Muscle spasms—Docetaxel—pancreatic cancer	0.000535	0.00105	CcSEcCtD
Frovatriptan—Dizziness—Sunitinib—pancreatic cancer	0.000527	0.00104	CcSEcCtD
Frovatriptan—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000527	0.00104	CcSEcCtD
Frovatriptan—Abdominal pain—Irinotecan—pancreatic cancer	0.000519	0.00102	CcSEcCtD
Frovatriptan—Body temperature increased—Irinotecan—pancreatic cancer	0.000519	0.00102	CcSEcCtD
Frovatriptan—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000518	0.00102	CcSEcCtD
Frovatriptan—Muscular weakness—Doxorubicin—pancreatic cancer	0.000509	0.000998	CcSEcCtD
Frovatriptan—Vomiting—Sunitinib—pancreatic cancer	0.000507	0.000995	CcSEcCtD
Frovatriptan—Body temperature increased—Gemcitabine—pancreatic cancer	0.000506	0.000993	CcSEcCtD
Frovatriptan—Headache—Sunitinib—pancreatic cancer	0.0005	0.000981	CcSEcCtD
Frovatriptan—Syncope—Docetaxel—pancreatic cancer	0.000499	0.000979	CcSEcCtD
Frovatriptan—Dysphagia—Doxorubicin—pancreatic cancer	0.000498	0.000978	CcSEcCtD
Frovatriptan—Pollakiuria—Epirubicin—pancreatic cancer	0.000498	0.000977	CcSEcCtD
Frovatriptan—Body temperature increased—Fluorouracil—pancreatic cancer	0.000497	0.000976	CcSEcCtD
Frovatriptan—Palpitations—Docetaxel—pancreatic cancer	0.000492	0.000965	CcSEcCtD
Frovatriptan—Loss of consciousness—Docetaxel—pancreatic cancer	0.000489	0.00096	CcSEcCtD
Frovatriptan—Hypersensitivity—Irinotecan—pancreatic cancer	0.000484	0.00095	CcSEcCtD
Frovatriptan—Convulsion—Docetaxel—pancreatic cancer	0.000482	0.000946	CcSEcCtD
Frovatriptan—Arthralgia—Docetaxel—pancreatic cancer	0.000474	0.00093	CcSEcCtD
Frovatriptan—Chest pain—Docetaxel—pancreatic cancer	0.000474	0.00093	CcSEcCtD
Frovatriptan—Myalgia—Docetaxel—pancreatic cancer	0.000474	0.00093	CcSEcCtD
Frovatriptan—Nausea—Sunitinib—pancreatic cancer	0.000474	0.00093	CcSEcCtD
Frovatriptan—Asthenia—Irinotecan—pancreatic cancer	0.000471	0.000925	CcSEcCtD
Frovatriptan—Stomatitis—Epirubicin—pancreatic cancer	0.000468	0.000919	CcSEcCtD
Frovatriptan—Conjunctivitis—Epirubicin—pancreatic cancer	0.000467	0.000916	CcSEcCtD
Frovatriptan—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000464	0.00091	CcSEcCtD
Frovatriptan—Dry mouth—Docetaxel—pancreatic cancer	0.000463	0.000909	CcSEcCtD
Frovatriptan—Pollakiuria—Doxorubicin—pancreatic cancer	0.00046	0.000904	CcSEcCtD
Frovatriptan—Asthenia—Gemcitabine—pancreatic cancer	0.000459	0.000901	CcSEcCtD
Frovatriptan—Confusional state—Docetaxel—pancreatic cancer	0.000458	0.000899	CcSEcCtD
Frovatriptan—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000454	0.000891	CcSEcCtD
Frovatriptan—Epistaxis—Epirubicin—pancreatic cancer	0.000453	0.000889	CcSEcCtD
Frovatriptan—Pruritus—Gemcitabine—pancreatic cancer	0.000453	0.000889	CcSEcCtD
Frovatriptan—Sinusitis—Epirubicin—pancreatic cancer	0.000451	0.000884	CcSEcCtD
Frovatriptan—Diarrhoea—Irinotecan—pancreatic cancer	0.000449	0.000882	CcSEcCtD
Frovatriptan—Shock—Docetaxel—pancreatic cancer	0.000447	0.000877	CcSEcCtD
Frovatriptan—Pruritus—Fluorouracil—pancreatic cancer	0.000445	0.000874	CcSEcCtD
Frovatriptan—Tachycardia—Docetaxel—pancreatic cancer	0.000443	0.00087	CcSEcCtD
Frovatriptan—Bradycardia—Epirubicin—pancreatic cancer	0.000439	0.000862	CcSEcCtD
Frovatriptan—Diarrhoea—Gemcitabine—pancreatic cancer	0.000438	0.000859	CcSEcCtD
Frovatriptan—Dizziness—Irinotecan—pancreatic cancer	0.000434	0.000853	CcSEcCtD
Frovatriptan—Haemoglobin—Epirubicin—pancreatic cancer	0.000433	0.000851	CcSEcCtD
Frovatriptan—Stomatitis—Doxorubicin—pancreatic cancer	0.000433	0.00085	CcSEcCtD
Frovatriptan—Anorexia—Docetaxel—pancreatic cancer	0.000433	0.00085	CcSEcCtD
Frovatriptan—Rhinitis—Epirubicin—pancreatic cancer	0.000432	0.000848	CcSEcCtD
Frovatriptan—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000432	0.000848	CcSEcCtD
Frovatriptan—Haemorrhage—Epirubicin—pancreatic cancer	0.000431	0.000846	CcSEcCtD
Frovatriptan—Diarrhoea—Fluorouracil—pancreatic cancer	0.00043	0.000845	CcSEcCtD
Frovatriptan—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000429	0.000842	CcSEcCtD
Frovatriptan—Pharyngitis—Epirubicin—pancreatic cancer	0.000428	0.00084	CcSEcCtD
Frovatriptan—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000426	0.000836	CcSEcCtD
Frovatriptan—Urethral disorder—Epirubicin—pancreatic cancer	0.000423	0.00083	CcSEcCtD
Frovatriptan—Epistaxis—Doxorubicin—pancreatic cancer	0.000419	0.000823	CcSEcCtD
Frovatriptan—Vomiting—Irinotecan—pancreatic cancer	0.000418	0.00082	CcSEcCtD
Frovatriptan—Sinusitis—Doxorubicin—pancreatic cancer	0.000417	0.000818	CcSEcCtD
Frovatriptan—Dizziness—Fluorouracil—pancreatic cancer	0.000416	0.000817	CcSEcCtD
Frovatriptan—Visual impairment—Epirubicin—pancreatic cancer	0.000415	0.000816	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000414	0.000812	CcSEcCtD
Frovatriptan—Headache—Irinotecan—pancreatic cancer	0.000412	0.000808	CcSEcCtD
Frovatriptan—Insomnia—Docetaxel—pancreatic cancer	0.000411	0.000806	CcSEcCtD
Frovatriptan—Paraesthesia—Docetaxel—pancreatic cancer	0.000408	0.0008	CcSEcCtD
Frovatriptan—Vomiting—Gemcitabine—pancreatic cancer	0.000407	0.000799	CcSEcCtD
Frovatriptan—Bradycardia—Doxorubicin—pancreatic cancer	0.000406	0.000797	CcSEcCtD
Frovatriptan—Dyspnoea—Docetaxel—pancreatic cancer	0.000405	0.000795	CcSEcCtD
Frovatriptan—Somnolence—Docetaxel—pancreatic cancer	0.000404	0.000792	CcSEcCtD
Frovatriptan—Tinnitus—Epirubicin—pancreatic cancer	0.000402	0.000789	CcSEcCtD
Frovatriptan—Haemoglobin—Doxorubicin—pancreatic cancer	0.000401	0.000787	CcSEcCtD
Frovatriptan—Headache—Gemcitabine—pancreatic cancer	0.000401	0.000787	CcSEcCtD
Frovatriptan—Flushing—Epirubicin—pancreatic cancer	0.0004	0.000785	CcSEcCtD
Frovatriptan—Vomiting—Fluorouracil—pancreatic cancer	0.0004	0.000785	CcSEcCtD
Frovatriptan—Rhinitis—Doxorubicin—pancreatic cancer	0.0004	0.000785	CcSEcCtD
Frovatriptan—Dyspepsia—Docetaxel—pancreatic cancer	0.0004	0.000785	CcSEcCtD
Frovatriptan—Haemorrhage—Doxorubicin—pancreatic cancer	0.000399	0.000783	CcSEcCtD
Frovatriptan—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000397	0.000779	CcSEcCtD
Frovatriptan—Pharyngitis—Doxorubicin—pancreatic cancer	0.000396	0.000777	CcSEcCtD
Frovatriptan—Decreased appetite—Docetaxel—pancreatic cancer	0.000395	0.000775	CcSEcCtD
Frovatriptan—Headache—Fluorouracil—pancreatic cancer	0.000394	0.000774	CcSEcCtD
Frovatriptan—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000394	0.000773	CcSEcCtD
Frovatriptan—Fatigue—Docetaxel—pancreatic cancer	0.000392	0.000769	CcSEcCtD
Frovatriptan—Urethral disorder—Doxorubicin—pancreatic cancer	0.000391	0.000768	CcSEcCtD
Frovatriptan—Nausea—Irinotecan—pancreatic cancer	0.00039	0.000766	CcSEcCtD
Frovatriptan—Pain—Docetaxel—pancreatic cancer	0.000388	0.000762	CcSEcCtD
Frovatriptan—Constipation—Docetaxel—pancreatic cancer	0.000388	0.000762	CcSEcCtD
Frovatriptan—Chills—Epirubicin—pancreatic cancer	0.000387	0.000759	CcSEcCtD
Frovatriptan—Arrhythmia—Epirubicin—pancreatic cancer	0.000385	0.000756	CcSEcCtD
Frovatriptan—Visual impairment—Doxorubicin—pancreatic cancer	0.000384	0.000755	CcSEcCtD
Frovatriptan—Nausea—Gemcitabine—pancreatic cancer	0.00038	0.000746	CcSEcCtD
Frovatriptan—Mental disorder—Epirubicin—pancreatic cancer	0.000378	0.000741	CcSEcCtD
Frovatriptan—Malnutrition—Epirubicin—pancreatic cancer	0.000375	0.000737	CcSEcCtD
Frovatriptan—Feeling abnormal—Docetaxel—pancreatic cancer	0.000374	0.000735	CcSEcCtD
Frovatriptan—Nausea—Fluorouracil—pancreatic cancer	0.000374	0.000734	CcSEcCtD
Frovatriptan—Tinnitus—Doxorubicin—pancreatic cancer	0.000372	0.00073	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000371	0.000729	CcSEcCtD
Frovatriptan—Flushing—Doxorubicin—pancreatic cancer	0.00037	0.000727	CcSEcCtD
Frovatriptan—Flatulence—Epirubicin—pancreatic cancer	0.00037	0.000726	CcSEcCtD
Frovatriptan—Tension—Epirubicin—pancreatic cancer	0.000368	0.000723	CcSEcCtD
Frovatriptan—Dysgeusia—Epirubicin—pancreatic cancer	0.000368	0.000721	CcSEcCtD
Frovatriptan—Nervousness—Epirubicin—pancreatic cancer	0.000365	0.000716	CcSEcCtD
Frovatriptan—Back pain—Epirubicin—pancreatic cancer	0.000363	0.000713	CcSEcCtD
Frovatriptan—Muscle spasms—Epirubicin—pancreatic cancer	0.000361	0.000708	CcSEcCtD
Frovatriptan—Abdominal pain—Docetaxel—pancreatic cancer	0.000359	0.000705	CcSEcCtD
Frovatriptan—Body temperature increased—Docetaxel—pancreatic cancer	0.000359	0.000705	CcSEcCtD
Frovatriptan—Chills—Doxorubicin—pancreatic cancer	0.000358	0.000703	CcSEcCtD
Frovatriptan—Arrhythmia—Doxorubicin—pancreatic cancer	0.000356	0.0007	CcSEcCtD
Frovatriptan—Mental disorder—Doxorubicin—pancreatic cancer	0.000349	0.000686	CcSEcCtD
Frovatriptan—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000348	0.000684	CcSEcCtD
Frovatriptan—Malnutrition—Doxorubicin—pancreatic cancer	0.000347	0.000682	CcSEcCtD
Frovatriptan—Agitation—Epirubicin—pancreatic cancer	0.000345	0.000677	CcSEcCtD
Frovatriptan—Flatulence—Doxorubicin—pancreatic cancer	0.000342	0.000672	CcSEcCtD
Frovatriptan—Tension—Doxorubicin—pancreatic cancer	0.000341	0.000669	CcSEcCtD
Frovatriptan—Dysgeusia—Doxorubicin—pancreatic cancer	0.00034	0.000668	CcSEcCtD
Frovatriptan—Malaise—Epirubicin—pancreatic cancer	0.000338	0.000664	CcSEcCtD
Frovatriptan—Nervousness—Doxorubicin—pancreatic cancer	0.000337	0.000662	CcSEcCtD
Frovatriptan—Vertigo—Epirubicin—pancreatic cancer	0.000337	0.000662	CcSEcCtD
Frovatriptan—Syncope—Epirubicin—pancreatic cancer	0.000337	0.000661	CcSEcCtD
Frovatriptan—Back pain—Doxorubicin—pancreatic cancer	0.000336	0.000659	CcSEcCtD
Frovatriptan—Hypersensitivity—Docetaxel—pancreatic cancer	0.000335	0.000657	CcSEcCtD
Frovatriptan—Muscle spasms—Doxorubicin—pancreatic cancer	0.000334	0.000655	CcSEcCtD
Frovatriptan—Palpitations—Epirubicin—pancreatic cancer	0.000332	0.000651	CcSEcCtD
Frovatriptan—Loss of consciousness—Epirubicin—pancreatic cancer	0.00033	0.000648	CcSEcCtD
Frovatriptan—Asthenia—Docetaxel—pancreatic cancer	0.000326	0.00064	CcSEcCtD
Frovatriptan—Convulsion—Epirubicin—pancreatic cancer	0.000325	0.000638	CcSEcCtD
Frovatriptan—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000322	0.000632	CcSEcCtD
Frovatriptan—Pruritus—Docetaxel—pancreatic cancer	0.000321	0.000631	CcSEcCtD
Frovatriptan—Chest pain—Epirubicin—pancreatic cancer	0.00032	0.000627	CcSEcCtD
Frovatriptan—Arthralgia—Epirubicin—pancreatic cancer	0.00032	0.000627	CcSEcCtD
Frovatriptan—Myalgia—Epirubicin—pancreatic cancer	0.00032	0.000627	CcSEcCtD
Frovatriptan—Agitation—Doxorubicin—pancreatic cancer	0.000319	0.000626	CcSEcCtD
Frovatriptan—Anxiety—Epirubicin—pancreatic cancer	0.000318	0.000625	CcSEcCtD
Frovatriptan—Discomfort—Epirubicin—pancreatic cancer	0.000316	0.00062	CcSEcCtD
Frovatriptan—Malaise—Doxorubicin—pancreatic cancer	0.000313	0.000615	CcSEcCtD
Frovatriptan—Dry mouth—Epirubicin—pancreatic cancer	0.000312	0.000613	CcSEcCtD
Frovatriptan—Vertigo—Doxorubicin—pancreatic cancer	0.000312	0.000612	CcSEcCtD
Frovatriptan—Syncope—Doxorubicin—pancreatic cancer	0.000311	0.000611	CcSEcCtD
Frovatriptan—Diarrhoea—Docetaxel—pancreatic cancer	0.000311	0.00061	CcSEcCtD
Frovatriptan—Confusional state—Epirubicin—pancreatic cancer	0.000309	0.000606	CcSEcCtD
Frovatriptan—Palpitations—Doxorubicin—pancreatic cancer	0.000307	0.000602	CcSEcCtD
Frovatriptan—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000306	0.000601	CcSEcCtD
Frovatriptan—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000305	0.000599	CcSEcCtD
Frovatriptan—Shock—Epirubicin—pancreatic cancer	0.000301	0.000592	CcSEcCtD
Frovatriptan—Convulsion—Doxorubicin—pancreatic cancer	0.000301	0.000591	CcSEcCtD
Frovatriptan—Dizziness—Docetaxel—pancreatic cancer	0.0003	0.000589	CcSEcCtD
Frovatriptan—Tachycardia—Epirubicin—pancreatic cancer	0.000299	0.000587	CcSEcCtD
Frovatriptan—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000296	0.000581	CcSEcCtD
Frovatriptan—Chest pain—Doxorubicin—pancreatic cancer	0.000296	0.00058	CcSEcCtD
Frovatriptan—Arthralgia—Doxorubicin—pancreatic cancer	0.000296	0.00058	CcSEcCtD
Frovatriptan—Myalgia—Doxorubicin—pancreatic cancer	0.000296	0.00058	CcSEcCtD
Frovatriptan—Anxiety—Doxorubicin—pancreatic cancer	0.000295	0.000578	CcSEcCtD
Frovatriptan—Discomfort—Doxorubicin—pancreatic cancer	0.000292	0.000573	CcSEcCtD
Frovatriptan—Anorexia—Epirubicin—pancreatic cancer	0.000292	0.000573	CcSEcCtD
Frovatriptan—Dry mouth—Doxorubicin—pancreatic cancer	0.000289	0.000568	CcSEcCtD
Frovatriptan—Vomiting—Docetaxel—pancreatic cancer	0.000289	0.000567	CcSEcCtD
Frovatriptan—Confusional state—Doxorubicin—pancreatic cancer	0.000286	0.000561	CcSEcCtD
Frovatriptan—Headache—Docetaxel—pancreatic cancer	0.000284	0.000558	CcSEcCtD
Frovatriptan—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000283	0.000556	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000279	0.000548	CcSEcCtD
Frovatriptan—Shock—Doxorubicin—pancreatic cancer	0.000279	0.000547	CcSEcCtD
Frovatriptan—Insomnia—Epirubicin—pancreatic cancer	0.000277	0.000544	CcSEcCtD
Frovatriptan—Tachycardia—Doxorubicin—pancreatic cancer	0.000277	0.000543	CcSEcCtD
Frovatriptan—Paraesthesia—Epirubicin—pancreatic cancer	0.000275	0.00054	CcSEcCtD
Frovatriptan—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000274	0.000538	CcSEcCtD
Frovatriptan—Dyspnoea—Epirubicin—pancreatic cancer	0.000273	0.000536	CcSEcCtD
Frovatriptan—Somnolence—Epirubicin—pancreatic cancer	0.000272	0.000535	CcSEcCtD
Frovatriptan—Anorexia—Doxorubicin—pancreatic cancer	0.00027	0.00053	CcSEcCtD
Frovatriptan—Nausea—Docetaxel—pancreatic cancer	0.00027	0.000529	CcSEcCtD
Frovatriptan—Dyspepsia—Epirubicin—pancreatic cancer	0.00027	0.000529	CcSEcCtD
Frovatriptan—Decreased appetite—Epirubicin—pancreatic cancer	0.000266	0.000523	CcSEcCtD
Frovatriptan—Fatigue—Epirubicin—pancreatic cancer	0.000264	0.000518	CcSEcCtD
Frovatriptan—Pain—Epirubicin—pancreatic cancer	0.000262	0.000514	CcSEcCtD
Frovatriptan—Constipation—Epirubicin—pancreatic cancer	0.000262	0.000514	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000258	0.000507	CcSEcCtD
Frovatriptan—Insomnia—Doxorubicin—pancreatic cancer	0.000256	0.000503	CcSEcCtD
Frovatriptan—Paraesthesia—Doxorubicin—pancreatic cancer	0.000254	0.0005	CcSEcCtD
Frovatriptan—Dyspnoea—Doxorubicin—pancreatic cancer	0.000253	0.000496	CcSEcCtD
Frovatriptan—Feeling abnormal—Epirubicin—pancreatic cancer	0.000252	0.000495	CcSEcCtD
Frovatriptan—Somnolence—Doxorubicin—pancreatic cancer	0.000252	0.000495	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00025	0.000492	CcSEcCtD
Frovatriptan—Dyspepsia—Doxorubicin—pancreatic cancer	0.000249	0.00049	CcSEcCtD
Frovatriptan—Decreased appetite—Doxorubicin—pancreatic cancer	0.000246	0.000484	CcSEcCtD
Frovatriptan—Fatigue—Doxorubicin—pancreatic cancer	0.000244	0.00048	CcSEcCtD
Frovatriptan—Constipation—Doxorubicin—pancreatic cancer	0.000242	0.000476	CcSEcCtD
Frovatriptan—Pain—Doxorubicin—pancreatic cancer	0.000242	0.000476	CcSEcCtD
Frovatriptan—Abdominal pain—Epirubicin—pancreatic cancer	0.000242	0.000475	CcSEcCtD
Frovatriptan—Body temperature increased—Epirubicin—pancreatic cancer	0.000242	0.000475	CcSEcCtD
Frovatriptan—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000234	0.000458	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000232	0.000455	CcSEcCtD
Frovatriptan—Hypersensitivity—Epirubicin—pancreatic cancer	0.000226	0.000443	CcSEcCtD
Frovatriptan—Body temperature increased—Doxorubicin—pancreatic cancer	0.000224	0.00044	CcSEcCtD
Frovatriptan—Abdominal pain—Doxorubicin—pancreatic cancer	0.000224	0.00044	CcSEcCtD
Frovatriptan—Asthenia—Epirubicin—pancreatic cancer	0.00022	0.000431	CcSEcCtD
Frovatriptan—Pruritus—Epirubicin—pancreatic cancer	0.000217	0.000425	CcSEcCtD
Frovatriptan—Diarrhoea—Epirubicin—pancreatic cancer	0.00021	0.000411	CcSEcCtD
Frovatriptan—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000209	0.00041	CcSEcCtD
Frovatriptan—Asthenia—Doxorubicin—pancreatic cancer	0.000203	0.000399	CcSEcCtD
Frovatriptan—Dizziness—Epirubicin—pancreatic cancer	0.000203	0.000398	CcSEcCtD
Frovatriptan—Pruritus—Doxorubicin—pancreatic cancer	0.000201	0.000394	CcSEcCtD
Frovatriptan—Vomiting—Epirubicin—pancreatic cancer	0.000195	0.000382	CcSEcCtD
Frovatriptan—Diarrhoea—Doxorubicin—pancreatic cancer	0.000194	0.000381	CcSEcCtD
Frovatriptan—Headache—Epirubicin—pancreatic cancer	0.000192	0.000377	CcSEcCtD
Frovatriptan—Dizziness—Doxorubicin—pancreatic cancer	0.000187	0.000368	CcSEcCtD
Frovatriptan—Nausea—Epirubicin—pancreatic cancer	0.000182	0.000357	CcSEcCtD
Frovatriptan—Vomiting—Doxorubicin—pancreatic cancer	0.00018	0.000354	CcSEcCtD
Frovatriptan—Headache—Doxorubicin—pancreatic cancer	0.000178	0.000349	CcSEcCtD
Frovatriptan—Nausea—Doxorubicin—pancreatic cancer	0.000168	0.00033	CcSEcCtD
Frovatriptan—HTR1D—Signaling Pathways—HEY1—pancreatic cancer	0.000114	0.000985	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PTHLH—pancreatic cancer	0.000114	0.000983	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PTCH1—pancreatic cancer	0.000114	0.000983	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SSTR1—pancreatic cancer	0.000113	0.00097	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SCT—pancreatic cancer	0.000112	0.000965	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HEY1—pancreatic cancer	0.000112	0.000965	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PPY—pancreatic cancer	0.00011	0.000951	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCK—pancreatic cancer	0.000109	0.00094	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SSTR2—pancreatic cancer	0.000108	0.000933	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCK—pancreatic cancer	0.000107	0.00092	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GLP1R—pancreatic cancer	0.000106	0.000916	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CNR2—pancreatic cancer	0.000106	0.000916	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CXCL8—pancreatic cancer	0.000106	0.000915	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CNR1—pancreatic cancer	0.000106	0.000914	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCKBR—pancreatic cancer	0.000105	0.000901	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCKAR—pancreatic cancer	0.000105	0.000901	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—SST—pancreatic cancer	0.000104	0.000899	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CNR2—pancreatic cancer	0.000104	0.000897	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GLP1R—pancreatic cancer	0.000104	0.000897	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000104	0.000897	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CXCL8—pancreatic cancer	0.000104	0.000896	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—GCG—pancreatic cancer	0.000102	0.000883	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCKAR—pancreatic cancer	0.000102	0.000882	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—JAG2—pancreatic cancer	0.000101	0.000874	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MEN1—pancreatic cancer	9.99e-05	0.000861	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—JAG2—pancreatic cancer	9.93e-05	0.000855	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—DTX4—pancreatic cancer	9.83e-05	0.000847	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GLI1—pancreatic cancer	9.83e-05	0.000847	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MEN1—pancreatic cancer	9.78e-05	0.000843	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AGTR1—pancreatic cancer	9.77e-05	0.000842	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CNR1—pancreatic cancer	9.63e-05	0.00083	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NRP1—pancreatic cancer	9.57e-05	0.000824	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PPP2R5B—pancreatic cancer	9.57e-05	0.000824	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SHH—pancreatic cancer	9.53e-05	0.000821	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOTCH4—pancreatic cancer	9.47e-05	0.000816	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IAPP—pancreatic cancer	9.41e-05	0.000811	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SHH—pancreatic cancer	9.33e-05	0.000804	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—GCG—pancreatic cancer	9.3e-05	0.000802	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOTCH4—pancreatic cancer	9.27e-05	0.000799	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IAPP—pancreatic cancer	9.22e-05	0.000794	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HEY2—pancreatic cancer	9.21e-05	0.000794	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PTCH1—pancreatic cancer	9.04e-05	0.000779	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PTHLH—pancreatic cancer	9.04e-05	0.000779	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GAST—pancreatic cancer	8.99e-05	0.000775	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AGTR1—pancreatic cancer	8.87e-05	0.000765	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PTHLH—pancreatic cancer	8.85e-05	0.000762	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PTCH1—pancreatic cancer	8.85e-05	0.000762	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SCT—pancreatic cancer	8.53e-05	0.000735	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HEY1—pancreatic cancer	8.53e-05	0.000735	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SST—pancreatic cancer	8.26e-05	0.000712	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PIK3CG—pancreatic cancer	8.15e-05	0.000702	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCK—pancreatic cancer	8.13e-05	0.000701	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SST—pancreatic cancer	8.09e-05	0.000697	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—JAG1—pancreatic cancer	8.09e-05	0.000697	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOTCH3—pancreatic cancer	8.05e-05	0.000694	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PIK3CG—pancreatic cancer	7.98e-05	0.000688	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CNR2—pancreatic cancer	7.93e-05	0.000683	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GLP1R—pancreatic cancer	7.93e-05	0.000683	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CXCL8—pancreatic cancer	7.92e-05	0.000683	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—JAG1—pancreatic cancer	7.92e-05	0.000682	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOTCH3—pancreatic cancer	7.89e-05	0.00068	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCKAR—pancreatic cancer	7.8e-05	0.000672	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CNR1—pancreatic cancer	7.63e-05	0.000657	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—JAG2—pancreatic cancer	7.56e-05	0.000652	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CNR1—pancreatic cancer	7.47e-05	0.000644	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MEN1—pancreatic cancer	7.45e-05	0.000642	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PIK3CG—pancreatic cancer	7.4e-05	0.000638	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GCG—pancreatic cancer	7.37e-05	0.000635	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3CG—pancreatic cancer	7.25e-05	0.000625	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GCG—pancreatic cancer	7.21e-05	0.000622	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.17e-05	0.000618	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SHH—pancreatic cancer	7.11e-05	0.000613	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOTCH4—pancreatic cancer	7.07e-05	0.000609	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AGTR1—pancreatic cancer	7.03e-05	0.000606	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IAPP—pancreatic cancer	7.02e-05	0.000605	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.02e-05	0.000605	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—STK11—pancreatic cancer	6.93e-05	0.000597	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AGTR1—pancreatic cancer	6.88e-05	0.000593	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—STK11—pancreatic cancer	6.78e-05	0.000584	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTHLH—pancreatic cancer	6.74e-05	0.000581	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTCH1—pancreatic cancer	6.74e-05	0.000581	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PRSS1—pancreatic cancer	6.73e-05	0.00058	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PIK3CD—pancreatic cancer	6.51e-05	0.000561	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3CD—pancreatic cancer	6.37e-05	0.000549	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.25e-05	0.000538	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SST—pancreatic cancer	6.16e-05	0.000531	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.12e-05	0.000527	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.08e-05	0.000524	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SMAD4—pancreatic cancer	6.07e-05	0.000523	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—JAG1—pancreatic cancer	6.03e-05	0.00052	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOTCH3—pancreatic cancer	6.01e-05	0.000518	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CXCL8—pancreatic cancer	6e-05	0.000517	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SMAD4—pancreatic cancer	5.94e-05	0.000512	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HES1—pancreatic cancer	5.92e-05	0.00051	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CXCL8—pancreatic cancer	5.88e-05	0.000506	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ARG2—pancreatic cancer	5.84e-05	0.000503	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HES1—pancreatic cancer	5.8e-05	0.0005	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CNR1—pancreatic cancer	5.69e-05	0.00049	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PIK3CB—pancreatic cancer	5.67e-05	0.000489	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3CB—pancreatic cancer	5.55e-05	0.000479	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CG—pancreatic cancer	5.52e-05	0.000476	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GCG—pancreatic cancer	5.49e-05	0.000473	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CXCL8—pancreatic cancer	5.45e-05	0.00047	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.34e-05	0.000461	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CXCL8—pancreatic cancer	5.34e-05	0.00046	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AGTR1—pancreatic cancer	5.24e-05	0.000452	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TERT—pancreatic cancer	5.19e-05	0.000447	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—STK11—pancreatic cancer	5.17e-05	0.000445	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TYMP—pancreatic cancer	5.1e-05	0.00044	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TERT—pancreatic cancer	5.08e-05	0.000438	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HIF1A—pancreatic cancer	4.96e-05	0.000428	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TSC2—pancreatic cancer	4.95e-05	0.000427	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HIF1A—pancreatic cancer	4.86e-05	0.000419	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CD—pancreatic cancer	4.85e-05	0.000418	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TSC2—pancreatic cancer	4.85e-05	0.000418	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOE—pancreatic cancer	4.85e-05	0.000418	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KDR—pancreatic cancer	4.75e-05	0.000409	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOE—pancreatic cancer	4.74e-05	0.000409	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.66e-05	0.000401	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KDR—pancreatic cancer	4.65e-05	0.000401	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SMAD4—pancreatic cancer	4.52e-05	0.00039	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NFKBIA—pancreatic cancer	4.51e-05	0.000389	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCL8—pancreatic cancer	4.48e-05	0.000386	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOTCH1—pancreatic cancer	4.47e-05	0.000385	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NFKBIA—pancreatic cancer	4.42e-05	0.000381	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HES1—pancreatic cancer	4.42e-05	0.000381	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOTCH1—pancreatic cancer	4.38e-05	0.000377	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CG—pancreatic cancer	4.37e-05	0.000377	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—NRAS—pancreatic cancer	4.37e-05	0.000377	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EGF—pancreatic cancer	4.32e-05	0.000372	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CG—pancreatic cancer	4.28e-05	0.000369	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—NRAS—pancreatic cancer	4.28e-05	0.000369	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EGF—pancreatic cancer	4.23e-05	0.000365	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CB—pancreatic cancer	4.23e-05	0.000365	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.21e-05	0.000363	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GLP1R—pancreatic cancer	4.11e-05	0.000354	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCL8—pancreatic cancer	4.07e-05	0.00035	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—DPYD—pancreatic cancer	4.05e-05	0.000349	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—EGFR—pancreatic cancer	3.98e-05	0.000343	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—EGFR—pancreatic cancer	3.9e-05	0.000336	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TERT—pancreatic cancer	3.87e-05	0.000334	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CD—pancreatic cancer	3.84e-05	0.000331	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	3.84e-05	0.000331	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.81e-05	0.000328	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.8e-05	0.000327	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CD—pancreatic cancer	3.76e-05	0.000324	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—KRAS—pancreatic cancer	3.76e-05	0.000324	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.73e-05	0.000321	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HIF1A—pancreatic cancer	3.7e-05	0.000319	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TSC2—pancreatic cancer	3.69e-05	0.000318	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—KRAS—pancreatic cancer	3.68e-05	0.000318	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.67e-05	0.000316	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOE—pancreatic cancer	3.61e-05	0.000311	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KDR—pancreatic cancer	3.54e-05	0.000305	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PIK3CA—pancreatic cancer	3.46e-05	0.000298	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3CA—pancreatic cancer	3.39e-05	0.000292	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NFKBIA—pancreatic cancer	3.37e-05	0.00029	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CB—pancreatic cancer	3.35e-05	0.000289	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.34e-05	0.000288	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOTCH1—pancreatic cancer	3.34e-05	0.000287	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CB—pancreatic cancer	3.28e-05	0.000283	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CG—pancreatic cancer	3.26e-05	0.000281	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—NRAS—pancreatic cancer	3.26e-05	0.000281	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EGF—pancreatic cancer	3.22e-05	0.000278	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCL8—pancreatic cancer	3.22e-05	0.000277	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HRAS—pancreatic cancer	3.2e-05	0.000276	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL8—pancreatic cancer	3.15e-05	0.000272	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HRAS—pancreatic cancer	3.13e-05	0.00027	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—AKT1—pancreatic cancer	3.11e-05	0.000268	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CASP3—pancreatic cancer	3.08e-05	0.000266	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—AKT1—pancreatic cancer	3.05e-05	0.000262	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CASP3—pancreatic cancer	3.02e-05	0.00026	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCND1—pancreatic cancer	3e-05	0.000259	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CD44—pancreatic cancer	2.97e-05	0.000256	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—EGFR—pancreatic cancer	2.97e-05	0.000256	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CTNNB1—pancreatic cancer	2.97e-05	0.000256	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCND1—pancreatic cancer	2.94e-05	0.000253	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MMP9—pancreatic cancer	2.91e-05	0.000251	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.91e-05	0.000251	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CTNNB1—pancreatic cancer	2.91e-05	0.000251	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PTEN—pancreatic cancer	2.9e-05	0.00025	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.89e-05	0.000249	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CD—pancreatic cancer	2.87e-05	0.000247	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MMP9—pancreatic cancer	2.85e-05	0.000246	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCG—pancreatic cancer	2.85e-05	0.000246	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.84e-05	0.000245	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PTEN—pancreatic cancer	2.83e-05	0.000244	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AKT1—pancreatic cancer	2.82e-05	0.000243	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—KRAS—pancreatic cancer	2.81e-05	0.000242	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AKT1—pancreatic cancer	2.77e-05	0.000238	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SRC—pancreatic cancer	2.68e-05	0.000231	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—STK11—pancreatic cancer	2.68e-05	0.000231	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SRC—pancreatic cancer	2.63e-05	0.000227	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—VEGFA—pancreatic cancer	2.62e-05	0.000225	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—STAT3—pancreatic cancer	2.59e-05	0.000223	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NRAS—pancreatic cancer	2.58e-05	0.000223	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	2.58e-05	0.000222	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—VEGFA—pancreatic cancer	2.56e-05	0.000221	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—STAT3—pancreatic cancer	2.54e-05	0.000218	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NRAS—pancreatic cancer	2.53e-05	0.000218	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.52e-05	0.000217	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CB—pancreatic cancer	2.5e-05	0.000215	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MYC—pancreatic cancer	2.41e-05	0.000207	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL8—pancreatic cancer	2.4e-05	0.000207	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TGFB1—pancreatic cancer	2.4e-05	0.000207	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	2.39e-05	0.000206	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MYC—pancreatic cancer	2.36e-05	0.000203	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EGFR—pancreatic cancer	2.35e-05	0.000203	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TGFB1—pancreatic cancer	2.35e-05	0.000203	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	2.32e-05	0.0002	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.31e-05	0.000199	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EGFR—pancreatic cancer	2.3e-05	0.000199	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	2.3e-05	0.000198	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	2.24e-05	0.000193	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KRAS—pancreatic cancer	2.22e-05	0.000192	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	2.22e-05	0.000191	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KRAS—pancreatic cancer	2.18e-05	0.000188	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	2.17e-05	0.000187	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	2.16e-05	0.000186	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	2.11e-05	0.000182	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CA—pancreatic cancer	2.04e-05	0.000176	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SRC—pancreatic cancer	2e-05	0.000173	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CA—pancreatic cancer	2e-05	0.000172	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TP53—pancreatic cancer	1.98e-05	0.00017	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	1.95e-05	0.000168	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TP53—pancreatic cancer	1.93e-05	0.000167	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	1.93e-05	0.000166	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	1.93e-05	0.000166	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HRAS—pancreatic cancer	1.89e-05	0.000163	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOE—pancreatic cancer	1.88e-05	0.000162	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	1.85e-05	0.000159	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MYC—pancreatic cancer	1.79e-05	0.000155	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	1.79e-05	0.000154	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.78e-05	0.000153	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	1.76e-05	0.000151	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.69e-05	0.000146	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	1.67e-05	0.000144	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	1.66e-05	0.000143	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	1.63e-05	0.000141	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.63e-05	0.000141	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.52e-05	0.000131	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.49e-05	0.000128	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TP53—pancreatic cancer	1.47e-05	0.000127	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	1.41e-05	0.000121	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.3e-05	0.000112	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.28e-05	0.000111	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	1.24e-05	0.000107	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.12e-05	9.66e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	7.91e-06	6.81e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKT1—pancreatic cancer	6.46e-06	5.57e-05	CbGpPWpGaD
